Gf Fund Management Co. Ltd. Atea Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,096 shares of AVIR stock, worth $6,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,096
Previous 1,773
18.22%
Holding current value
$6,812
Previous $5.94 Million
5.51%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$29.6 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24.7 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$15.6 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$15.4 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$8.08 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $271M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...